PHARMAC will be running a commercial process to fund medicines for rare disorders – a request for proposals (RFP). A draft of the RFP is attached to this letter. The objective of this process is to improve patients’ access to medicines for rare disorders.

The release of the draft RFP and this consultation letter follows a discussion on the scope and shape of the fund, and the type of medicines it might cover. PHARMAC would like feedback on the contents and process outlined in the draft RFP before the agency proceeds to the next stage, which would be actively seeking proposals from pharmaceutical suppliers.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2014-07-08-rare-disorders/